Cargando…
1333 Therapeutic HSV-2 vaccine (GEN003) results in durable reduction in genital lesions at 1 year
| Autores principales: | , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Oxford University Press
2014
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5781666/ http://dx.doi.org/10.1093/ofid/ofu051.150 |
| _version_ | 1783295009164886016 |
|---|---|
| author | Wald, Anna Warren, Terri Fife, Kenneth Tyring, Stephen Lee, Patricia Van Wagoner, Nicholas Bernstein, David Flechtner, Jessica B. Magaret, Amalia Morris, Amy Hetherington, Seth |
| author_facet | Wald, Anna Warren, Terri Fife, Kenneth Tyring, Stephen Lee, Patricia Van Wagoner, Nicholas Bernstein, David Flechtner, Jessica B. Magaret, Amalia Morris, Amy Hetherington, Seth |
| author_sort | Wald, Anna |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-5781666 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2014 |
| publisher | Oxford University Press |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-57816662018-03-01 1333 Therapeutic HSV-2 vaccine (GEN003) results in durable reduction in genital lesions at 1 year Wald, Anna Warren, Terri Fife, Kenneth Tyring, Stephen Lee, Patricia Van Wagoner, Nicholas Bernstein, David Flechtner, Jessica B. Magaret, Amalia Morris, Amy Hetherington, Seth Open Forum Infect Dis IDWeek 2014 Abstracts Oxford University Press 2014-12 2014-12 /pmc/articles/PMC5781666/ http://dx.doi.org/10.1093/ofid/ofu051.150 Text en © The Author 2014. Published by Oxford University Press on behalf of the Infectious Diseases Society of America |
| spellingShingle | IDWeek 2014 Abstracts Wald, Anna Warren, Terri Fife, Kenneth Tyring, Stephen Lee, Patricia Van Wagoner, Nicholas Bernstein, David Flechtner, Jessica B. Magaret, Amalia Morris, Amy Hetherington, Seth 1333 Therapeutic HSV-2 vaccine (GEN003) results in durable reduction in genital lesions at 1 year |
| title | 1333 Therapeutic HSV-2 vaccine (GEN003) results in durable reduction in genital lesions at 1 year |
| title_full | 1333 Therapeutic HSV-2 vaccine (GEN003) results in durable reduction in genital lesions at 1 year |
| title_fullStr | 1333 Therapeutic HSV-2 vaccine (GEN003) results in durable reduction in genital lesions at 1 year |
| title_full_unstemmed | 1333 Therapeutic HSV-2 vaccine (GEN003) results in durable reduction in genital lesions at 1 year |
| title_short | 1333 Therapeutic HSV-2 vaccine (GEN003) results in durable reduction in genital lesions at 1 year |
| title_sort | 1333 therapeutic hsv-2 vaccine (gen003) results in durable reduction in genital lesions at 1 year |
| topic | IDWeek 2014 Abstracts |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5781666/ http://dx.doi.org/10.1093/ofid/ofu051.150 |
| work_keys_str_mv | AT waldanna 1333therapeutichsv2vaccinegen003resultsindurablereductioningenitallesionsat1year AT warrenterri 1333therapeutichsv2vaccinegen003resultsindurablereductioningenitallesionsat1year AT fifekenneth 1333therapeutichsv2vaccinegen003resultsindurablereductioningenitallesionsat1year AT tyringstephen 1333therapeutichsv2vaccinegen003resultsindurablereductioningenitallesionsat1year AT leepatricia 1333therapeutichsv2vaccinegen003resultsindurablereductioningenitallesionsat1year AT vanwagonernicholas 1333therapeutichsv2vaccinegen003resultsindurablereductioningenitallesionsat1year AT bernsteindavid 1333therapeutichsv2vaccinegen003resultsindurablereductioningenitallesionsat1year AT flechtnerjessicab 1333therapeutichsv2vaccinegen003resultsindurablereductioningenitallesionsat1year AT magaretamalia 1333therapeutichsv2vaccinegen003resultsindurablereductioningenitallesionsat1year AT morrisamy 1333therapeutichsv2vaccinegen003resultsindurablereductioningenitallesionsat1year AT hetheringtonseth 1333therapeutichsv2vaccinegen003resultsindurablereductioningenitallesionsat1year |